7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 
      
    		                  
      assets
    		                  
      current assets:
    		                  
      cash and cash equivalents
    		29,633,000 40,355,000 28,000,000 16,706,000 16,720,000 24,445,000 32,645,000 9,692,000 9,859,000 8,753,000 11,012,000 11,834,000 8,912,000 24,004,000 24,132,000 24,361,000 68,278,000 41,731,000 
      short-term investments
    		197,883,000 187,136,000 201,341,000 220,517,000 220,400,000 208,839,000 92,709,000 117,490,000 122,023,000 138,340,000 142,927,000 93,968,000 103,923,000 104,616,000 119,715,000 134,971,000 99,985,000 19,998,000 
      accounts receivable
    		24,151,000 28,058,000 30,958,000 30,050,000 25,368,000 25,723,000 21,550,000 20,281,000 15,244,000 13,295,000 12,668,000 10,956,000 9,020,000 6,884,000 5,626,000 4,862,000 4,357,000 3,936,000 
      inventories
    		28,950,000 25,061,000 23,574,000 22,009,000 21,673,000 19,443,000 18,700,000 17,421,000 18,924,000 17,945,000 18,067,000 14,835,000 15,336,000 11,622,000 8,490,000 8,032,000 9,442,000 8,543,000 
      prepaid and other current assets
    		3,260,000 3,264,000 4,541,000 4,541,000 2,607,000 2,773,000 2,955,000 3,523,000 1,897,000 2,112,000 2,992,000 2,962,000 1,971,000 2,802,000 3,184,000 4,069,000 4,274,000 1,338,000 
      total current assets
    		283,877,000 283,874,000 288,414,000 293,823,000 286,768,000 281,223,000 168,559,000 168,407,000 167,947,000 180,445,000 187,666,000 134,555,000 139,162,000 149,928,000 161,147,000 176,295,000 186,336,000 75,546,000 
      property and equipment
    		13,096,000 13,255,000 12,557,000 12,413,000 12,241,000 12,444,000 11,617,000 10,841,000 10,262,000 10,533,000 9,804,000 10,138,000 10,620,000 11,083,000 10,915,000 11,217,000 11,991,000 12,686,000 
      operating leases right-of-use assets
    		10,276,000 10,588,000 10,922,000 11,217,000 10,536,000 10,818,000 2,052,000 2,444,000 2,793,000 3,174,000 3,555,000 3,943,000 4,331,000 4,704,000 4,057,000 4,284,000 4,561,000 4,749,000 
      restricted cash
    		748,000 750,000 750,000 750,000 711,000 711,000 711,000 711,000 711,000 761,000 761,000 761,000 811,000 811,000 811,000 811,000 561,000 561,000 
      other assets
    		536,000 542,000 401,000 360,000 213,000 303,000 226,000 147,000 137,000 348,000 746,000 767,000 782,000 188,000 132,000 114,000 287,000 1,344,000 
      total assets
    		308,533,000 309,009,000 313,044,000 318,563,000 310,469,000 305,499,000 183,165,000 182,550,000 181,850,000 195,261,000 202,532,000 150,164,000 155,706,000 166,714,000 177,062,000 192,721,000 203,736,000 94,886,000 
      liabilities and stockholders' equity
    		                  
      current liabilities:
    		                  
      accounts payable
    		3,377,000 3,348,000 7,111,000 4,544,000 4,581,000 5,095,000 5,057,000 3,863,000 4,105,000 3,997,000 3,717,000 2,595,000 4,172,000 3,277,000 2,587,000 1,689,000 1,691,000 2,342,000 
      accrued expenses and other current liabilities
    		17,621,000 15,934,000 14,575,000 20,358,000 17,323,000 13,787,000 11,657,000 15,239,000 12,861,000 10,588,000 9,181,000 12,672,000 10,248,000 7,877,000 6,409,000 7,859,000 6,016,000 4,781,000 
      lease liabilities
    		1,293,000 1,101,000 1,055,000 974,000 734,000 736,000 1,614,000 1,801,000 1,976,000 1,980,000 1,978,000 1,970,000 1,948,000 1,842,000 1,663,000 1,529,000 1,469,000 1,365,000 
      total current liabilities
    		22,291,000 20,383,000 22,741,000 25,876,000 22,638,000 19,618,000 18,328,000 20,903,000 18,942,000 16,565,000 14,876,000 17,237,000 16,368,000 12,996,000 10,659,000 11,077,000 9,176,000 11,102,000 
      long-term lease liabilities
    		10,272,000 10,614,000 10,987,000 11,322,000 10,570,000 10,674,000 908,000 1,211,000 1,354,000 1,843,000 2,338,000 2,856,000 3,354,000 3,851,000 3,350,000 3,642,000 4,033,000 4,374,000 
      other long-term liabilities
    		   127,000    74,000 75,000 76,000         
      total liabilities
    		32,563,000 30,997,000 33,728,000 37,325,000 33,208,000 30,292,000 19,236,000 22,188,000 20,371,000 38,073,000 57,523,000 60,262,000 59,747,000 56,728,000 53,899,000 54,479,000 52,845,000 54,982,000 
      commitments and contingencies
    		                  
      stockholders' equity:
    		                  
      common stock
    		41,000 41,000 41,000 40,000 40,000 40,000 37,000 36,000 36,000 35,000 34,000 28,000 28,000 27,000 27,000    
      preferred stock, 0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding
    		                  
      additional paid-in capital
    		927,756,000 920,159,000 909,545,000 903,127,000 892,857,000 885,104,000 767,685,000 754,971,000 746,966,000 730,274,000 704,228,000 636,001,000 626,491,000 623,746,000 620,106,000 617,511,000 614,418,000 137,838,000 
      accumulated other comprehensive income
    		60,000 -117,000 15,000  521,000              
      accumulated deficit
    		-651,887,000 -642,071,000 -630,285,000 -622,095,000 -616,157,000 -609,819,000 -603,740,000 -594,640,000 -585,463,000 -573,048,000 -559,244,000 -546,032,000 -530,422,000 -513,604,000 -496,872,000 -479,276,000 -463,543,000 -450,870,000 
      total stockholders' equity
    		275,970,000 278,012,000 279,316,000 281,238,000 277,261,000 275,207,000 163,929,000 160,362,000 161,479,000 157,188,000 145,009,000 89,902,000 95,959,000 109,986,000 123,163,000 138,242,000 150,891,000  
      total liabilities and stockholders' equity
    		308,533,000 309,009,000 313,044,000 318,563,000 310,469,000 305,499,000 183,165,000 182,550,000 181,850,000 195,261,000 202,532,000 150,164,000 155,706,000 166,714,000 177,062,000    
      accumulated other comprehensive loss
    		   166,000  -118,000 -53,000 -5,000 -60,000 -73,000 -9,000 -95,000 -138,000 -183,000 -98,000 -20,000 -11,000 -3,000 
      term loan
    		         19,589,000 40,309,000 40,169,000 40,025,000 39,881,000 39,890,000 39,760,000 39,636,000 39,506,000 
      preferred stock, 0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding as of march 31, 2022 and december 31, 2021
    		                  
      liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' equity
    		                  
      warrant liability
    		                 2,614,000 
      long-term warrant liability
    		                  
      redeemable common stock:
    		                  
      notes receivable for common stock issued
    		                  
      redeemable stock options
    		                  
      convertible preferred stock:
    		                  
      preferred stock, 0.001 par value, no shares authorized, issued or outstanding as of december 31, 2021 and 16,572,792 shares authorized, 14,376,272 shares issued and outstanding as of december 31, 2020
    		                  
      stockholders' equity
    		                  
      series g common stock, 0.001 par value, no share authorized or outstanding as of december 31, 2021 and 1 share authorized, issued and outstanding as of december 31, 2020
    		                  
      series w common stock, 0.001 par value, no share authorized, issued or outstanding as of december 31, 2021 and 1 share authorized and no share outstanding as of december 31, 2020
    		                  
      total liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' equity
    		               192,721,000 203,736,000  
      preferred stock, 0.001 par value, no shares authorized, issued or outstanding as of september 30, 2021 and 16,572,792 shares authorized, 14,376,272 shares issued and outstanding as of december 31, 2020
    		                  
      stockholders' deficit:
    		                  
      preferred stock, 0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding as of september 30, 2021
    		                  
      series g common stock, 0.001 par value, no share authorized or outstanding as of september 30, 2021 and 1 share authorized, issued and outstanding as of december 31, 2020
    		                  
      series w common stock, 0.001 par value, no share authorized, issued or outstanding as of september 30, 2021 and 1 share authorized and no share outstanding as of december 31, 2020
    		                  
      the balance sheet at december 31,2020 has been derived from the audited consolidated financial statements included in rxsight, inc.'s final prospectus for its public offering filed on july 29, 2021.
    		                  
      liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' deficit
    		                  
      preferred stock, 0.001 par value, 16,572,792 shares authorized, 14,376,272 shares issued and outstanding as of june 30, 2021 and december 31, 2020 (redeemable), respectively
    		                 353,300,000 
      series g common stock, 0.001 par value, 1 share authorized and outstanding as of june 30, 2021 and december 31, 2020
    		                  
      series w common stock, 0.001 par value, 1 share authorized and no shares outstanding as of june 30, 2021 and december 31, 2020
    		                  
      total stockholders' deficit
    		                 -313,396,000 
      total liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' deficit
    		                 94,886,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.